The ABCB1, CYP2C19, CYP3A5 and CYP4F2 genetic polymorphisms and platelet reactivity in the early phases of acute coronary syndromes
KB Mirzaev, E Rytkin, KA Ryzhikova… - Drug metabolism and …, 2018 - degruyter.com
Background The aim was to study seven polymorphic markers of genes encoding proteins
involved in the absorption, metabolism and pharmacokinetics of clopidogrel among patients …
involved in the absorption, metabolism and pharmacokinetics of clopidogrel among patients …
MicroRNAs as novel biomarkers for P2Y12–inhibitors resistance prediction
E Rytkin, K Mirzaev, I Bure, K Akmalova… - Pharmacogenomics …, 2021 - Taylor & Francis
Aim The aim of this study is to assess 6 micro-RNAs: miR-126, miR-223, miR-150, miR-29,
miR-34, miR-142 as potential biomarkers for P2Y12-inhibitors resistance prediction …
miR-34, miR-142 as potential biomarkers for P2Y12-inhibitors resistance prediction …
[PDF][PDF] The ABCB1, CYP2C19, CYP3A5 and CYP4F2 genetic polymorphisms and platelet reactivity in the early phases of acute coronary syndromes
DS Fedorinov, OD Konova, MI Giliarov, GA Belyakova… - xn--80aaalkavmenpjw0bt.xn--p1ai
Background: The aim was to study seven polymorphic markers of genes encoding proteins
involved in the absorption, metabolism and pharmacokinetics of clopidogrel among patients …
involved in the absorption, metabolism and pharmacokinetics of clopidogrel among patients …